We are live on ! Find out more
GHSI

Guardion Health Sciences, Inc. Common Stock

Delisted

GHSI was delisted on the 11th of October, 2024.

0 hedge funds and large institutions have $0 invested in Guardion Health Sciences, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

8.29% less ownership

Funds ownership: 8.29%0% (-8.3%)

100% less funds holding

Funds holding: 150 (-15)

100% less capital invested

Capital invested by funds: $588K → $0 (-$588K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 15

Holders
Holders Change
-15
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
15
Calls
Puts
Net Calls
Net Calls Change

GHSI Hedge Fund Activity: Q4 2024 in Review

0 of the 7,608 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q4 2024, worth a combined $0 — down 100% from $588K a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of GHSI and 0 opened new positions — a net loss of 15 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Renaissance Technologies, exiting entirely with an estimated $215K sold.

  • 0 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q4 2024, down from 15 in Q3 2024.
  • Funds reported $0 of Guardion Health Sciences, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q4 2024 and 15 closed out, a net change of -15 holders.
  • The largest Guardion Health Sciences, Inc. Common Stock seller in Q4 2024 was Renaissance Technologies, an estimated $215K sold.

Based on aggregated 13F filings for Q4 2024.